Last updated: July 18, 2024
Sponsor: National University of Ireland, Galway, Ireland
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes (Pediatric)
Pregnancy Complications
Diabetes And Hypertension
Treatment
No intervention as the study is observational.
Clinical Study ID
NCT06327191
23-CRFG-21
23-CRFG-21
Ages 18-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participation in the original EMERGE trial and consenting to further follow up.
Exclusion
Exclusion Criteria:
- EMERGE trial participants who did not provide consent for further follow up studies.
Study Design
Total Participants: 321
Treatment Group(s): 1
Primary Treatment: No intervention as the study is observational.
Phase:
Study Start date:
July 09, 2024
Estimated Completion Date:
December 31, 2025
Connect with a study center
University Hospital Galway
Galway,
IrelandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.